학술논문

Risks and benefits of Twitter use by hematologists/oncologists in the era of digital medicine
Document Type
article
Source
Seminars in Hematology. 54(4)
Subject
Biomedical and Clinical Sciences
Cardiovascular Medicine and Haematology
Hematology
Cancer
Patient Safety
Clinical Research
Humans
Oncologists
Risk Assessment
Social Media
Telemedicine
Twitter
Social media
Health information
Hematologist-Oncologist
Patient education
Digital engagement
Collaboration for Outcomes on Social Media in Oncology
Hematologist–Oncologist
Cardiorespiratory Medicine and Haematology
Immunology
Cardiovascular medicine and haematology
Language
Abstract
Twitter use by physicians, including those in the hematology-oncology field, is increasing. This microblogging platform provides a means to communicate and collaborate on a global scale. For the oncology professional, an active Twitter presence provides opportunities for continuing medical education, patient engagement and education, personal branding, and reputation management. However, because Twitter is an open, public forum, potential risks such as patient privacy violations, personal information disclosures, professionalism lapses, and time management need to be considered and managed. The authors have summarized the benefits and risks of Twitter use by the hematology-oncology physician. In addition, strategies to maximize benefit and minimize risk are discussed, and resources for additional learning are provided.